TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Indoco Remedies Limited ( (IN:INDOCO) ) has shared an announcement.
Indoco Remedies Limited announced that the Goods and Service Tax (GST) Authority has dropped proceedings against the company regarding a Show Cause Notice (SCN) related to issues like excess claim of Input Tax Credit (ITC) and GSTR9C reconciliation. The resolution of this matter indicates no financial or operational impact on the company, which is a positive development for its stakeholders and market positioning.
More about Indoco Remedies Limited
Indoco Remedies Limited operates in the pharmaceutical industry, providing a range of products including formulations and active pharmaceutical ingredients. The company focuses on both domestic and international markets, catering to various therapeutic segments.
YTD Price Performance: -29.78%
Average Trading Volume: 7,050
Current Market Cap: 21.5B INR
Learn more about INDOCO stock on TipRanks’ Stock Analysis page.